$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Cognitive effects of nicotine

Biological psychiatry, v.49 no.3, 2001년, pp.258 - 267  

Rezvani, Amir H (Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina USA) ,  Levin, Edward D (Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina USA)

Abstract AI-Helper 아이콘AI-Helper

AbstractNicotine and other nicotinic agonists have been found to improve performance on attention and memory tasks. Clinical studies using nicotine skin patches have demonstrated the efficacy of nicotine in treating cognitive impairments associated with Alzheimer’s disease, schizophrenia, and ...

주제어

참고문헌 (95)

  1. Am J Psychiatry Adler 150 1856 1993 10.1176/ajp.150.12.1856 Normalization of auditory physiology by cigarette smoking in schizophrenic patients 

  2. Pharmacol Biochem Behav Arendash 52 517 1995 10.1016/0091-3057(95)00119-H Nicotine enhances the learning and memory of aged rats 

  3. Brain Res Arendash 674 252 1995 10.1016/0006-8993(94)01449-R Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21 

  4. Arneric 3 2000 Nicotine in Psychiatry Neurobiology and clinical pathophysiology of neuronal nicotinic acetylcholine receptors 

  5. Behav Neural Biol Brioni 59 57 1993 10.1016/0163-1047(93)91159-K Nicotinic receptor agonists facilitate retention of avoidance training-participation of dopaminergic mechanisms 

  6. Brain Res Clarke 323 390 1984 10.1016/0006-8993(84)90320-2 Autoradiographic distribution of nicotine receptors in rat brain 

  7. Psychopharmacology Colrain 108 448 1992 10.1007/BF02247419 Effects of post-learning smoking on memory consolidation 

  8. Psychopharmacol Bull Conners 32 67 1996 Nicotine and attention in adult ADHD 

  9. Science Coyle 219 1184 1983 10.1126/science.6338589 Alzheimer’s disease 

  10. Soc Neurosci Abstr Cregan 15 731 1989 Spatial working memory enhancement by nicotine of aged Long-Evans rats in the T-maze 

  11. Biol Psychiatry Decina 28 502 1990 10.1016/0006-3223(90)90483-I Cigarette smoking and neuroleptic-induced Parkinsonism 

  12. Life Sci Decker 56 545 1995 10.1016/0024-3205(94)00488-E Diversity of neuronal nicotinic acetylcholine receptors 

  13. Eur J Pharmacol Decker 261 217 1994 10.1016/0014-2999(94)90323-9 Effects of ABT-418, a novel cholinergic channel ligand, on place learning in septal-lesioned rats 

  14. Pharmacol Biochem Behav Decker 45 571 1993 10.1016/0091-3057(93)90508-Q Effects of lobeline, a nicotinic receptor agonist, on learning and memory 

  15. Behav Neurosci Dunnett 104 655 1990 10.1037/0735-7044.104.5.655 Proactive interference effects on short-term memory in rats 

  16. Neuroscience Felix 81 1009 1997 10.1016/S0306-4522(97)00224-8 Nicotinic antagonist administration into the ventral hippocampus and spatial working memory in rats 

  17. Biol Psychiatry Freedman 38 22 1995 10.1016/0006-3223(94)00252-X Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia 

  18. J Neurosci Freedman 13 1965 1993 10.1523/JNEUROSCI.13-05-01965.1993 Alpha-Bungarotoxin binding to hippocampal interneurons-immunocytochemical characterization and effects on growth factor expression 

  19. Giacobini 367 1988 Nicotinic Acetylcholine Receptors in the Nervous System The cholinergic receptor system in the frontal lobe of Alzheimer’s patients 

  20. Nature Gray 383 713 1996 10.1038/383713a0 Hippocampal synaptic transmission enhanced by low concentrations of nicotine 

  21. Neurobiol Learn Memory Grigoryan 65 135 1996 10.1006/nlme.1996.0016 6-OHDA lesions of the nucleus accumbens accentuate memory deficits in animals with lesions to the forebrain cholinergic projection system 

  22. Pharmacol Biochem Behav Grigoryan 49 511 1994 10.1016/0091-3057(94)90063-9 Are the cognitive-enhancing effects of nicotine in the rat with lesions to the forebrain cholinergic projection system mediated by an interaction with the noradrenergic system? 

  23. Neurosci Res Hamid 29 81 1997 10.1016/S0168-0102(97)00074-6 Nicotine induces long-lasting potentiation in the dentate gyrus of nicotine-primed rats 

  24. J Subst Abuse Hatsukami 1 407 1989 10.1016/S0899-3289(20)30005-5 The effects of varying cigarette deprivation duration on cognitive and performance tasks 

  25. Exp Clin Psychopharmacol Heishman 2 1 1994 Nicotine and smoking 

  26. Am J Psychiatry Hughes 143 993 1996 Prevalence of smoking among psychiatric outpatients 

  27. Behav Brain Res Jarrard 71 1 1995 10.1016/0166-4328(95)00034-8 What does the hippocampus really do? 

  28. Psychopharmacology Jones 108 485 1992 10.1007/BF02247426 Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer’s disease 

  29. Kellar 341 1990 Nicotine Psychopharmacology Nicotinic cholinergic receptors in Alzheimer’s disease 

  30. Brain Res Kim 725 231 1996 10.1016/0006-8993(96)00213-2 Nicotinic, muscarinic and dopaminergic actions in the ventral hippocampus and the nucleus accumbens 

  31. Schizophr Bull Leonard 22 431 1996 10.1093/schbul/22.3.431 Nicotinic receptor function in schizophrenia 

  32. Psychopharmacology Levin 108 418 1992 10.1007/BF02247415 Nicotine systems and cognitive function 

  33. Soc Neurosci Abstr Levin 24 183 1998 AR-R 17779, an a7 nicotinic agonist improves learning and memory in rats 

  34. Behav Pharmacol Levin 4 179 1993 10.1097/00008877-199304000-00010 Chronic nicotinic stimulation and blockade effects on working memory 

  35. Physiol Behav Levin 61 863 1997 10.1016/S0031-9384(96)00609-9 Chronic nicotinic agonist and antagonist effects on T-maze alternation 

  36. Drug Dev Res Levin 39 29 1996 10.1002/(SICI)1098-2299(19960901)39:1<29::AID-DDR4>3.0.CO;2-M Chronic nicotine-induced improvement of spatial working memory and D2 dopamine effects in rats 

  37. Brain Res Cogn Brain Res Levin 1 137 1993 10.1016/0926-6410(93)90021-V Chronic nicotine reverses working memory deficits caused by lesions of the fimbria or medial basalocortical projection 

  38. Brain Res Cogn Brain Res Levin 7 405 1999 10.1016/S0926-6410(98)00044-5 Ventral hippocampal ibotenic acid lesions block chronic nicotine-induced spatial working memory improvement in rats 

  39. Psychopharmacology Levin 140 135 1998 10.1007/s002130050750 Transdermal nicotine effects on attention 

  40. Psychopharmacology Levin 123 55 1996 10.1007/BF02246281 Nicotine effects on adults with attention-deficit/hyperactivity disorder 

  41. Drug Dev Res Levin 46 107 1999 10.1002/(SICI)1098-2299(199902)46:2<107::AID-DDR3>3.0.CO;2-C Bridged nicotine, isonicotine, and norisonicotine effects on working memory performance of rats in the radial-arm maze 

  42. Behav Pharmacol Levin 8 236 1997 Acute nicotine interactions with nicotinic and muscarinic antagonists 

  43. Psychopharmacology Levin 127 25 1996 10.1007/BF02805971 Chronic nicotine effects on working and reference memory in the 16-arm radial maze 

  44. Behav Neural Biol Levin 53 269 1990 10.1016/0163-1047(90)90509-5 Chronic nicotine and withdrawal effects on radial-arm maze performance in rats 

  45. Eur J Pharmacol Levin 393 141 2000 10.1016/S0014-2999(99)00885-7 Development of nicotinic drug therapy for cognitive disorders 

  46. Behav Pharmacol Levin 1 511 1990 10.1097/00008877-199000160-00005 Anticholinergic sensitivity following chronic nicotine administration as measured by radial-arm maze performance in rats 

  47. Pharmacol Biochem Behav Levin 51 369 1995 10.1016/0091-3057(94)00406-9 Effects of nicotinic dimethylaminoethyl esters on working memory performance of rats in the radial-arm maze 

  48. Psychopharmacology Levin 138 217 1998 10.1007/s002130050667 Nicotinic acetylcholine involvement in cognitive function in animals 

  49. Levin 203 2000 Nicotine in Psychiatry Nicotine effects and attention deficit disorder 

  50. Med Chem Res Levin 6 543 1996 Epibatidine, a potent nicotinic agonist 

  51. Levin 329 1995 International Symposium on Nicotine Nicotine effects on memory performance 

  52. Psychopharmacology Levin 123 88 1996 10.1007/BF02246285 Acute and chronic nicotine effects on working memory in aged rats 

  53. Neuropsychopharmacology Levin 15 429 1996 10.1016/S0893-133X(96)00018-8 Nicotine-haloperidol interactions and cognitive performance in schizophrenics 

  54. Neurosci Biobehav Rev Martin 5 473 1981 10.1016/0149-7634(81)90017-8 Nicotine binding sites and their localization in the central nervous system 

  55. Psychopharmacology Muir 118 82 1995 10.1007/BF02245253 Reversal of visual attentional dysfunction following lesions of the cholinergic basal forebrain by physostigmine and nicotine but not by the 5-HT3 receptor antagonist, ondansetron 

  56. Drugs Aging Newhouse 11 206 1997 10.2165/00002512-199711030-00005 Nicotinic system involvement in Alzheimer’s and Parkinson’s diseases 

  57. Psychopharmacology Newhouse 95 171 1988 10.1007/BF00174504 Intravenous nicotine in Alzheimer’s disease 

  58. Behav Brain Res Nordberg 57 215 1993 10.1016/0166-4328(93)90138-G Clinical studies in Alzheimer patients with positron emission tomography 

  59. Nordberg 45 1995 Brain Imaging of Nicotine and Tobacco Smoking Imaging of nicotinic receptors in human brain 

  60. Neurosci Lett Nordberg 88 317 1988 10.1016/0304-3940(88)90503-4 Change in nicotinic receptor subtypes in temporal cortex of Alzheimer brains 

  61. Pharmacol Biochem Behav Ohno 45 89 1993 10.1016/0091-3057(93)90091-7 Blockade of hippocampal nicotinic receptors impairs working memory but not reference memory in rats 

  62. J Pharmacol Exp Ther Pacheco 274 767 1995 Cholinesterase inhibitors proposed for treating dementia in Alzheimer’s Disease 

  63. Neuropsychol Rev Parks 6 61 1996 10.1007/BF01875368 Increased regional cerebral glucose metabolism and semantic memory performance in Alzheimer’s disease 

  64. J Neurol Neurosurg Psychiatry Perry 50 806 1987 10.1136/jnnp.50.6.806 Nicotinic receptor abnormalities in Alzheimer’s and Parkinson’s diseases 

  65. Can J Neurol Sci Quirion 13 503 1986 10.1017/S0317167100037215 Neurotransmitter and receptor deficits in senile dementia of the Alzheimer’s type 

  66. Neurology Raskind 54 2261 2000 10.1212/WNL.54.12.2261 Galantamine in AD 

  67. Brain Res Ridley 376 108 1986 10.1016/0006-8993(86)90904-2 Learning impairment following lesion of basal nucleus of Meynert in the marmoset 

  68. Brain Res Rinne 547 167 1991 10.1016/0006-8993(91)90588-M A postmortem study of brain nicotinic receptors in Parkinson’s and Alzheimer’s disease 

  69. J Pharmacol Exp Ther Rochford 277 1267 1996 Effect of nicotine and nicotinic receptor agonists on latent inhibition in the rat 

  70. Psychopharmacology Rusted 138 362 1998 10.1007/s002130050682 Effortful processing is a requirement for nicotine-induced improvement in memory 

  71. Psychopharmacology Rusted 119 405 1995 10.1007/BF02245856 Effects of post-trial administration of nicotine on human memory 

  72. 10.1007/978-3-0348-7457-1_79 Sahakian BJ, Jones GMM (1991): The effects of nicotine on attention, information processing, and working memory in patients with dementia of the Alzheimer type. In: Adlkofer F, Thruau K, editors. Effects of Nicotine on Biological Systems. Basel, Switzerland: Birkhauser Verlag, 623-230. 

  73. Biochemistry Salomon 35 13568 1996 10.1021/bi9617264 Nicotine inhibits amyloid formation by the beta-peptide 

  74. Harv Rev Psychiatry Samuels 6 11 1998 10.3109/10673229809010950 Experimental approaches to cognitive disturbance in Alzheimer’s disease 

  75. Pharmacol Biochem Behav Sasaki 38 921 1991 10.1016/0091-3057(91)90265-4 Nicotine improves cognitive disturbance in rodents fed with a choline-deficient diet 

  76. Schroder 73 1995 Brain Imaging of Nicotine and Tobacco Smoking Nicotinic receptors in Alzheimer’s disease 

  77. Life Sci Schwartz 38 2111 1986 10.1016/0024-3205(86)90210-9 Autoradiographic distribution of high affinity muscarinic and nicotinic cholinergic receptors labled with [3H] acetylcholine in rat brain 

  78. J Neurochem Shimohama 46 288 1986 10.1111/j.1471-4159.1986.tb12960.x Changes in nicotinic and muscarinic receptors in Alzheimer-type dementia 

  79. Dementia Snaedal 7 47 1996 The effcts of nicotine in dermal plaster on cognitive functions in patients with Alzheimer’s disease 

  80. Neurobiol Aging Socci 16 857 1995 10.1016/0197-4580(95)00091-R Nicotine enhances Morris water maze performance of young and aged rats 

  81. Neuroscience Stancampiano 89 1135 1999 10.1016/S0306-4522(98)00397-2 Serotonin and acetylcholine release response in the rat hippocampus during a spatial memory task 

  82. Standaert 503 1996 Goodman & Gilman’s the Pharmacological Basis of Therapeutics Treatment of central nervous system degenerative disorders 

  83. J Neurosci Res Sugaya 27 349 1990 10.1002/jnr.490270314 Nicotinic acetylcholine receptor subtypes in human frontal cortex 

  84. Neurology Tariot 54 2269 2000 10.1212/WNL.54.12.2269 A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group 

  85. Drug Dev Res Terry 40 304 1997 10.1002/(SICI)1098-2299(199704)40:4<304::AID-DDR4>3.0.CO;2-N Cholinergic channel activator, ABT-418, enhances delayed-response accuracy in rats 

  86. Psychopharmacology Terry 123 172 1996 10.1007/BF02246174 Effects of stimulation or blockade of central nicotinic-cholinergic receptors on performance of a novel version of the rat stimulus discrimination task 

  87. Psychopharmacology Warburton 135 305 1998 10.1007/s002130050514 Evaluation of the information processing and mood effects of a transdermal nicotine patch 

  88. Psychopharmacology Warburton 115 539 1994 10.1007/BF02245578 Improvements in performance without nicotine withdrawal 

  89. Psychopharmacology White 143 158 1999 10.1007/s002130050931 Four week nicotine skin patch treatment effects on cognitive performance in Alzheimer’s disease 

  90. Am J Psychiatry Wilens 156 1931 1999 10.1176/ajp.156.12.1931 A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder 

  91. Br J Psychol Williams 71 83 1980 10.1111/j.2044-8295.1980.tb02732.x Effects of cigarette smoking on immediate memory and performance in different kinds of smoker 

  92. Pharmacol Biochem Behav Wilson 51 509 1995 10.1016/0091-3057(95)00043-V Nicotine patches in Alzheimer’s disease 

  93. Trends Neurosci Wonnacott 20 92 1997 10.1016/S0166-2236(96)10073-4 Presynaptic nicotinic ACh receptors 

  94. Prog Brain Res Wonnacott 79 157 1989 10.1016/S0079-6123(08)62475-9 Presynaptic modulation of transmitter release by nicotinic receptors 

  95. Eur J Pharmacol Zarrindast 295 1 1996 10.1016/0014-2999(95)00628-1 Effects of nicotine on memory retrieval in mice 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로